bioRxiv · 10.1101/2020.06.06.138123
Expression and T cell Regulatory Action of the PD-1 Immune Checkpoint in the Ovary and Fallopian Tube
Abstract
The Programmed Cell Death Protein-1 (PD-1/PDCD-1/CD279) checkpoint has powerful immunomodulatory action, including in the context of cancer. PD-1 receptor activation by its ligands (PD-L1/2) is associated with downregulated immune response, and tumor cells can avoid surveillance via PD-1 and/or ligand expression. While receptor expression is largely limited to lymphoid, myeloid, and tumor cells, we show that membrane bound and soluble variants of PD-1 and ligands are also expressed by permanent constituent cell types of the human ovary and fallopian tube, including granulosa cells and oocytes. PD-1 and soluble ligands were highly enriched in exosome fractions in human follicular fluid at bioactive levels that can control T cell PD-1 activation. PD-1 checkpoint signaling may be involved in physiological ovarian functions including follicle, and ultimately, germline and embryo immune-privilege.Competing Interest StatementThe authors have declared no competing interest.View Full Text
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Johnson, J., Sam, P. K., Asokan, R., Llerena Cari, E., Bales, E. S., Luu, T.-H., Perez, L., Kallen, A. N., Nel-Themaat, L., Polotsky, A. J., Post, M. D., Orlicky, D. J., Jordan, K. R., Bitler, B. G.. 2020-06-07. Expression and T cell Regulatory Action of the PD-1 Immune Checkpoint in the Ovary and Fallopian Tube. https://doi.org/10.1101/2020.06.06.138123
Cite the original work for its findings. Save a collection to share your selection of sources.